TrialInternational journal of hematology2019

Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study).

Hirokazu Murakami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.